Correlation of MIB-1 antigen expression with transcription factors Skn- 1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia

Journal of Pathology

Volumn 183, Issue 3, 1997, Pages 305-310

  Hietala, Kustaa A ^a   Kosma, Veli Matti ^a   Syrjänen, Kari J ^a   Syrjänen, Stina M ^b   Kellokoski, Jari K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cell proliferation; Cervix; CIN; HPV; MIB 1; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRECANCER; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL DIVISION; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA-BINDING PROTEINS; FEMALE; HOMEODOMAIN PROTEINS; HOST CELL FACTOR C1; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-1; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0030659416     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199711)183:3<305::AID-PATH922>3.0.CO;2-F     Document Type: Article

References (29)

1. Turek LP. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv Virus Res 1994; 44: 305-356.
2. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-363.
3. Weidner N, Moore DH II, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel 'paraffin'-reactive MIB1 antibody. Hum Pathol 1994; 25: 337-342.
4. Youssef EM, Matsuda T, Takada N, et al Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 1995; 76: 358-366.
5. Keshgegian AA, Cnaan A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen. Ki-67 and MIB-1. Am J Clin Pathol 1995; 104: 42-49.
6. Nagao T, Kondo F, Sato T, Nagato Y, Kondo Y. Immunohistochemical detection of aberrant p53 expression in hepalocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining. Hum Pathol 1995; 26: 326-333.
7. Bulten J, Van Der Laak JA, Gemmink JH, Pahlplatz MM, De Wilde PC, Hanselaar AG. MIB-1, a promising marker for the classification of cervical intraepithelial neoplasia. J Pathol 1996; 178: 268-273.
8. Resnick M, Lester S, Tate JE, Sheets EE, Sparks C, Crum CP. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. Hum Pathol 1996; 27: 234-239.
9. Al-Saleh W, Delvenne P, Greimers R, Fridman V, Doyen J, Boniver J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol 1995; 104: 154-160.
10. Latchman DS. Transcription-factor mutations and disease. N Engl J Med 1996; 334: 28-33.
11. Andersen B, Schonemann MD, Flynn SE, Pearse RV II, Singh H, Rosenfeld MG. Skn-la and Skn-li: two functionally distinct Oct-2-related factors expressed in epidermis. Science 1993; 260: 78-82.
12. Yukawa K, Butz K, Yasui T, Kikutani H, Hoppe-Seyler F. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/Skn-la. J Virol 1996; 70: 10-16.
13. Verrijzer CP, Kal AJ, Van Der Vliet PC. The DNA binding domain (POU domain) of transcription factor Oct-1 suffices for stimulation of DNA replication. EMBO J 1990; 9: 1883-1888.
14. Luo Y, Fujii H, Gerster T, Roeder RG. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 1992; 71: 231-241.
15. Morris PJ, Dent CL, Ring CJ, Latchman DS. The octamer binding site in the HPV 16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res 1993; 21: 1019-1023.
16. Leask A, Byrne C, Fuchs E. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc Natl Acad Sci USA 1991; 88: 7948-7952.
17. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 1991; 5: 105-119.
18. Buettner R, Kannan P, Imhof A, et al. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 1993; 13: 4174-4185.
19. Royer HD, Freyaldenhoven MP, Napierski I, Spitkovsky DD, Bauknecht T, Dathan N. Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated. Nucleic Acids Res 1991; 19: 2363-2371.
20. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RB, ed. Blaustein's Pathology of the Female Genital Tract. 4th edn. New York: Springer-Verlag, 1994; 279-326.
21. Chang F, Syrjänen S, Shen Q, Wang L, Syrjänen K. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 1993; 72: 2525-2530.
22. Isacson C, Kessis TD, Hedrick L, Cho KR. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 1996; 54: 669-674.
23. Heatley MK. Proliferation in the normal cervix and in preinvasive cervical lesions (Editorial). J Clin Pathol 1996; 49: 957.
24. Faus I, Hsu HJ, Fuchs E. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol Cell Biol 1994; 14: 3263-3275.
25. Tanaka M, Herr W. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 1990; 60: 375-386.
26. Sibbet GJ, Cuthill S, Campo MS. The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol 1995; 69: 4006-4011.
27. Hoppe-Seyler F, Butz K, Zur Hausen H. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol 1991; 65: 5613-5618.
28. Snape AM, Winning RS, Sargent TD. Transcription factor AP-2 is tissue-specific in Xenopus and is closely related or identical to keratin transcription factor 1 (KTF-1). Development 1991; 113: 283-293.
29. Mercurio F, Karin M. Transcription factors AP-3 and AP-2 interact with the SV40 enhancer in a mutually exclusive manner. EMBO J 1989; 8: 1455-1460.